HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy. The post HealthTap Introduces Virtual Primary Care Program for DME Suppliers appeared first on MedCity News .
Ultragenyx Pharmaceutical sold two priority review vouchers, each from an FDA approval of a gene therapy. Both therapies came from business deals and proceeds from the voucher sales put Ultragenyx in a better financial position to pursue yet another deal…
Healthleap, a clinical AI platform that works within the EHR to screen hospitalized patients for conditions that might otherwise go undiagnosed, is supporting hospitals in finding at-risk patients sooner. The post Healthleap Raises $38M to Expand AI Screening for Overlooked…
Many hospitals are now trying to use AI to automate processes and free up staff time, running simultaneous pilots to perform as many tasks as possible. This quickly leads to pilot sprawl — a state where organizations can no longer…
These service providers, formerly known as geriatric care managers, can arrange a move to a senior living facility, deal with Medicare and Medicaid, recommend doctors, drive a client to the dentist, and much more.
An initiative on the California ballot would levy the nation’s first wealth tax on billionaires. Supporters say the proceeds would help offset President Donald Trump’s sweeping healthcare cuts. But critics argue that the temporary infusion of cash is a giveaway…
Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or external calibration. The post Happy Health’s Cuffless BP Device Wins FDA Clearance appeared first on MedCity News .
Roche gains global rights to a Rona Therapeutics RNA interference drug designed to target ALK7, a genetically validated target for obesity and other metabolic indications. The growing field of companies pursuing ALK7 includes GSK and Arrowhead Pharmaceuticals. The post Roche…
Medicare policy should be transparent and include appropriate notice and stakeholder input. And when a contractor gets it wrong, there should be a clear and rapid way to stop the harm to patients, their relationship with their doctor and the…
A doctor has recommended a course of action that is invasive, expensive, or somehow different from what you'd prefer. Is it OK to get a second opinion? The answer is yes. Here’s how to make the ask a little less…
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make…